Cargando…

Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B

The ectodomain of the influenza A virus (IAV) hemagglutinin (HA) stem is highly conserved across strains and has shown promise as a universal influenza vaccine in a mouse model. In this study, potential B-cell epitopes were found through sequence alignment and epitope prediction in a stem fragment,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Xin, Yin, He, Shi, Yuhua, He, Xiaoqiu, Yu, Yongjiao, Guan, Shanshan, Kuai, Ziyu, Haji, Nasteha M, Haji, Nafisa M, Kong, Wei, Shan, Yaming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893548/ https://www.ncbi.nlm.nih.gov/pubmed/27222326 http://dx.doi.org/10.1038/emi.2016.51

Ejemplares similares

The immunogenicity of chimeric antibodies
Publicado: (1989)

Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults
por: Fadlyana, Eddy, et al.
Publicado: (2023)

Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity
por: Xia, Ming, et al.
Publicado: (2022)

Safety and immunogenicity of 3 seasonal trivalent influenza vaccines in the Chinese military
por: Gao, Dongqi, et al.
Publicado: (2016)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
por: Mo, Zhaojun, et al.
Publicado: (2017)

Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults
por: Spencer, Sarah, et al.
Publicado: (2021)

Intranasal administration of immunogenic poly-epitope from influenza H1N1 and H3N2 viruses adjuvanted with chitin and chitosan microparticles in BALB/c mice
por: Sadeghi, Sahar, et al.
Publicado: (2021)

Exploration of binding and inhibition mechanism of a small molecule inhibitor of influenza virus H1N1 hemagglutinin by molecular dynamics simulation
por: Guan, Shanshan, et al.
Publicado: (2017)

Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge
por: kumar, Subaschandrabose Rajesh, et al.
Publicado: (2015)

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs
por: Awasthi, Sita, et al.
Publicado: (2017)

Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem
por: Jiang, Wenbo, et al.
Publicado: (2020)

Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer
por: Kotecha, Rishi S., et al.
Publicado: (2015)

Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
por: Cohen, Kristen W., et al.
Publicado: (2023)

Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis
por: Schenk, Julie, et al.
Publicado: (2021)

Comparative Immunogenicity of Bacterially Expressed Soluble Trimers and Nanoparticle Displayed Influenza Hemagglutinin Stem Immunogens
por: Kar, Uddipan, et al.
Publicado: (2022)

Immunogenicity and Blocking Efficacy of Norovirus GII.4 Recombinant P Protein Vaccine
por: Yu, Zhendi, et al.
Publicado: (2023)

Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use with Inactivated or Adenovirus Vaccines
por: Lin, Shih-Chang, et al.
Publicado: (2011)

Modulation of Immunogenicity and Conformation of HA1 Subunit of Influenza A Virus H1/N1 Hemagglutinin in Tubular Immunostimulating Complexes
por: Sanina, Nina, et al.
Publicado: (2017)

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
por: Beran, Jiří, et al.
Publicado: (2013)

Immunogenicity of a Trivalent Human Papillomavirus L1 DNA-Encapsidated, Non-Replicable Baculovirus Nanovaccine
por: Cho, Hansam, et al.
Publicado: (2014)

The Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccination: A Study of Maternal-Cord Blood Pairs in Taiwan
por: Lin, Shin-Yu, et al.
Publicado: (2013)

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection
por: Sanchez Alberti, Andrés, et al.
Publicado: (2017)

Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development
por: Premanand, Balraj, et al.
Publicado: (2018)

Synthesis of Azido-Globo H Analogs for Immunogenicity Evaluation
por: Chen, Chiang-Yun, et al.
Publicado: (2021)

Safety and Immunogenicity of H5N1 Influenza Vaccine Based on Baculovirus Surface Display System of Bombyx mori
por: Jin, Rongzhong, et al.
Publicado: (2008)

Immunogenic evaluation of chimeric recombinant protein against ETEC, EHEC and Shigella
por: Khalouie, Farzane, et al.
Publicado: (2017)

Structural prediction of chimeric immunogens to elicit targeted antibodies against betacoronaviruses
por: Simpson, Jamel, et al.
Publicado: (2023)

Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants
por: Moreira, Gustavo Marçal Schmidt Garcia, et al.
Publicado: (2016)

Immunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal Salmonella Glycoconjugate Formulation
por: Baliban, Scott M., et al.
Publicado: (2018)

Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants
por: Moonsamy, Shelina, et al.
Publicado: (2019)

Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children
por: Ang, Jann Catherine, et al.
Publicado: (2019)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
por: Carregaro, Rodrigo Luiz, et al.
Publicado: (2023)

Immunogenicity evaluation of MS2 phage-mediated chimeric nanoparticle displaying an immunodominant B cell epitope of foot-and-mouth disease virus
por: Wang, Guoqiang, et al.
Publicado: (2018)

Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine
por: Chen, Wei, et al.
Publicado: (2020)

In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications
por: Amani, Jafar, et al.
Publicado: (2009)

Safety, Immunogenicity, and Protective Efficacy of an H5N1 Chimeric Cold-Adapted Attenuated Virus Vaccine in a Mouse Model
por: Sun, Weiyang, et al.
Publicado: (2021)

1954. A Randomized Study to Evaluate the Shedding and Immunogenicity of H1N1 Strains in Trivalent and Quadrivalent Formulations of FluMist in Children 24 to <48 Months of Age
por: Mallory, Raburn, et al.
Publicado: (2018)

Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses
por: Ge, Pan, et al.
Publicado: (2023)

Identification of Novel Immunogenic Proteins of Neisseria gonorrhoeae by Phage Display
por: Connor, Daniel O., et al.
Publicado: (2016)

Gold Nanoclusters Display Low Immunogenic Effect in Microglia Cells
por: Sobska, Joanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_019ajnbphgrbn8n13ig2332l5i